Pantoprazole 40 mg solution for injection

This tender, originating from Bulgaria and published via the TED (Tenders Electronic Daily) platform, seeks the supply of Pantoprazole 40 mg, specifically in a powder for solution for injection formulation. The procurement is for a quantity of 30,000 units. This represents a pharmaceutical supply tender, crucial for healthcare provision within the specified region.

The contracting authority, managed by the Publications Office of the European Union, is looking to establish a reliable source for this essential medication. Prospective suppliers will be evaluated based on their ability to meet stringent quality standards and ensure consistent delivery of pharmaceutical-grade products. Typical requirements for such tenders include demonstrated compliance with Good Manufacturing Practices (GMP), relevant pharmacopoeia standards (e.g., European Pharmacopoeia), and robust quality control procedures. Bidders are expected to provide comprehensive documentation regarding their manufacturing facilities, quality assurance systems, and product specifications. Furthermore, evidence of prior experience in supplying similar pharmaceutical products to public healthcare systems or international organizations may be advantageous. The tender process will likely involve detailed technical evaluations of the proposed product and the supplier's capabilities, alongside commercial considerations. Successful bidders will be responsible for the secure packaging, labeling, and timely delivery of the Pantoprazole 40 mg powder for solution for injection to designated locations within Bulgaria.